about
Maximizing Effectiveness Trials in PTSD and SUD Through Secondary Analysis: Benefits and Limitations Using the National Institute on Drug Abuse Clinical Trials Network "Women and Trauma" Study as a Case Example.Antiretroviral medication treatment for all HIV-infected individuals: a protocol using innovative multilevel methodologies to evaluate New York City's universal ART policy among problem substance users.Technology-Based Interventions for Substance Use and Comorbid Disorders: An Examination of the Emerging Literature.Addiction Research Training Programs: Four Case Studies and Recommendations for Evaluation.Racial/ethnic subgroup differences in outcomes and acceptability of an Internet-delivered intervention for substance use disorders."It's Never Just About the HIV:" HIV Primary Care Providers' Perception of Substance Use in the Era of "Universal" Antiretroviral Medication Treatment.No evidence of compensatory drug use risk behavior among heroin users after receiving take-home naloxone.Future directions for medication assisted treatment for opioid use disorder with American Indian/Alaska NativesDeveloping an opioid use disorder treatment cascade: A review of quality measuresInterpretation and integration of the federal substance use privacy protection rule in integrated health systems: A qualitative analysisCognitive functioning and treatment outcomes in a randomized controlled trial of internet-delivered drug and alcohol treatmentGender differences in demographic and clinical characteristics of patients with opioid use disorder entering a comparative effectiveness medication trialResponding to the Opioid Crisis: Lessons From a Review of Casualties
P50
Q35901022-77A8A4A3-6134-45AB-B967-9A7ADB80A06AQ36093277-14F2155C-4FCC-4C28-B7EA-BDEA27A5E91EQ38687378-F672E8EA-C881-44AE-892A-ACBC6DF2DF15Q38738627-E4C5876E-7A4A-4445-B3F4-44D091493062Q38860794-6FEE0D7A-1E45-47E9-BA2B-6119219EF353Q47562198-C4D82F87-82FB-4D6B-80B8-6C13A6159207Q52312417-C46F2C60-BB46-4A4E-8D3E-A13D25466AABQ57128063-29A9F7F7-1C64-49E0-8B0A-9DF2AF4A0D04Q89128932-2DFBE61A-A0A5-4E2F-A5A5-C3EEA6B4A43AQ90708293-B67BFAA5-AEE4-4EAB-A17E-CD13E48FA5E0Q90851325-C0BC0D10-407B-411D-97BA-90DC6AE03C30Q90938053-6B21B46E-444B-471A-B4DC-57A305401217Q91294537-29BB5EFE-209B-49EF-B2D4-F80EE56813BF
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Aimee N C Campbell
@en
Aimee N C Campbell
@nl
type
label
Aimee N C Campbell
@en
Aimee N C Campbell
@nl
prefLabel
Aimee N C Campbell
@en
Aimee N C Campbell
@nl
P31
P496
0000-0003-4247-9980